Select Page

Early-stage breast cancer detection from urine: pain-free, radiation-free

Pain-free, low-cost, sensitive, radiation-free device to detect breast cancer in urine

The problem

1 In 8 Women

will have breast cancer
at least once

BC is the most treatable cancer

but women, specially those with dense breast tissue, do not have reliable
screening methods available

It still remains the #1 cancer killer for women

81% of them want to get tested
for breast cancer

THE SOLUTION

We’re building a pain-free, radiation-free and accessible breast cancer test for them

Our Mission

Breast cancer is the most treatable cancer, yet it remains the #1 cancer killer for women, as 50% are detected too late. At The Blue Box, we’ve built a urine-based breast cancer test with a sensitivity of 88.42%, outperforming mammography by 15%-30%. We’ll run clinical trials in 2025 and launch in gynecology clinics by 2026.

Scientific Validation

Logo Blue Box Biomedical

During 3 years, we’ve collaborated with 7 hospitals, with over 450 women participating in our study

Pius Hospital de Valls
Hospital Universitario La Paz
Hospital Universitario Infanta Sofía
Hospital Universitari Dexeus
Hospital Joan XXIII
Hospital Universitari Sant Joan
Consorci Sanitari de Terrassa

The Blue Box – Featured at

The Blue Box – Supported By:

Join The Blue Box Family!

Logo Blue Box Biomedical

Do you want to be the first to know when The Blue Box will hit the market?

Subscribe to our newsletter and never miss out on The Blue Box journey!

The Blue Box
Privacy summary

This page uses cookies so that we can offer you the best possible user experience. Cookies information is being stored in your browser. Cookies perform functions such as remembering and recognizing you when you come back to our page or helping our team understand which parts of the page are most interesting and useful to you.

Here you can read more about our privacy policy.